Loading...
Outcomes Following ATG Therapy for Chronic Lung Allograft Dysfunction
Chronic lung allograft dysfunction (CLAD) is the major factor limiting survival post lung transplantation (LTx) with limited effective therapeutic options. We report our 12-y experience of antithymocyte globulin (ATG) as second-line CLAD therapy. METHODS. Clinical and lung function data were collect...
Na minha lista:
| Udgivet i: | Transplant Direct |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7969305/ https://ncbi.nlm.nih.gov/pubmed/33748410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001134 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|